Erudio Healtherudio.com
Sponsor
CG Oncology trials: what clinicians said in public
No HCP commentary report on a trial sponsored by CG Oncology yet. Erudio has found public clinician commentary on 3 clinical trials sponsored by CG Oncology: BOND-003, CORE-008 and PIVOT-006. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (CG Oncology, Inc.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| BOND-003 NCT04452591 · CG Oncology, Inc. DeepView → | BCG-unresponsive high-risk non-muscle-invasive bladder cancer | Phase 3 | Deep | View | |||
| PIVOT-006 NCT06111235 · CG Oncology, Inc. DeepView → | intermediate-risk non-muscle invasive bladder cancer | Phase 3 | Deep | View | |||
| CORE-008 NCT06567743 · CG Oncology, Inc. DeepView → | high-risk non-muscle-invasive bladder cancer | Phase 2 | Deep | View | |||